Stephen P. Carey
CIK: 0001674236
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ANI PHARMACEUTICALS INC
Discretionary Trading P&L
Holdings
Transaction History (27 total)
- Oct 29, 2026ANIP
ANI PHARMACEUTICALS INC
Sale(S)Direct2.9K shares at avg. $72.87$208K - Sep 29, 2026ANIP
ANI PHARMACEUTICALS INC
Sale(S)Direct2.9K shares at avg. $73.00$208K - Aug 31, 2026ANIP
ANI PHARMACEUTICALS INC
Sale(S)Direct2.9K shares at avg. $72.80$207K - Jul 29, 2026ANIP
ANI PHARMACEUTICALS INC
Sale(S)Direct2.9K shares at avg. $81.36$232K - Jul 2, 2026ANIP
ANI PHARMACEUTICALS INC
Exercise(M)Direct3.3K shares at avg. $49.51$164K - Jul 2, 2026ANIP
ANI PHARMACEUTICALS INC
Sale(S)Direct3.3K shares at avg. $86.00$285K - Jun 29, 2026ANIP
ANI PHARMACEUTICALS INC
Sale(S)Direct2.9K shares at avg. $84.12$240K - Jun 5, 2026ANIP
ANI PHARMACEUTICALS INC
Exercise(M)Direct3.3K shares at avg. $49.51$164K - Jun 5, 2026ANIP
ANI PHARMACEUTICALS INC
Sale(S)Direct3.3K shares at avg. $80.00$265K - Mar 7, 2026ANIP
ANI PHARMACEUTICALS INC
Tax Payment(F)Direct5.2K shares at avg. $74.04$381K - Mar 5, 2026ANIP
ANI PHARMACEUTICALS INC
Sale(S)Direct3.3K shares at avg. $75.42$250K - Mar 5, 2026ANIP
ANI PHARMACEUTICALS INC
Sale(S)Direct4K shares at avg. $75.56$302K - Mar 5, 2026ANIP
ANI PHARMACEUTICALS INC
Exercise(M)Direct3.3K shares at avg. $49.51$164K - Feb 28, 2026ANIP
ANI PHARMACEUTICALS INC
Tax Payment(F)Direct2.8K shares at avg. $73.90$205K - Feb 26, 2026ANIP
ANI PHARMACEUTICALS INC
Award(A)Direct22.2K shares at avg. $77.15$1.7M - Feb 14, 2026ANIP
ANI PHARMACEUTICALS INC
Tax Payment(F)Direct2.4K shares at avg. $77.36$189K - Feb 12, 2026ANIP
ANI PHARMACEUTICALS INC
Tax Payment(F)Direct2.8K shares at avg. $76.70$217K - Feb 11, 2026ANIP
ANI PHARMACEUTICALS INC
Tax Payment(F)Direct5.5K shares at avg. $76.25$420K - Aug 12, 2025ANIP
ANI PHARMACEUTICALS INC
Exercise(M)Direct50K shares at avg. $46.49$2.3M - Aug 12, 2025ANIP
ANI PHARMACEUTICALS INC
Sale(S)Direct50K shares at avg. $86.07$4.3M - Mar 23, 2025ANIP
ANI PHARMACEUTICALS INC
Tax Payment(F)Direct6.2K shares at avg. $64.26$399K - Mar 7, 2025ANIP
ANI PHARMACEUTICALS INC
Tax Payment(F)Direct5.2K shares at avg. $60.62$312K - Feb 28, 2025ANIP
ANI PHARMACEUTICALS INC
Tax Payment(F)Direct1.9K shares at avg. $61.89$115K - Feb 14, 2025ANIP
ANI PHARMACEUTICALS INC
Tax Payment(F)Direct1.7K shares at avg. $58.92$102K - Feb 12, 2025ANIP
ANI PHARMACEUTICALS INC
Award(A)Direct16.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 29, 2026 | ANIP ANI PHARMACEUTICALS INC | Sale(S) | 2,850 | $72.87 | $207,680 | Direct |
| Sep 29, 2026 | ANIP ANI PHARMACEUTICALS INC | Sale(S) | 2,850 | $73.00 | $208,050 | Direct |
| Aug 31, 2026 | ANIP ANI PHARMACEUTICALS INC | Sale(S) | 2,850 | $72.80 | $207,480 | Direct |
| Jul 29, 2026 | ANIP ANI PHARMACEUTICALS INC | Sale(S) | 2,850 | $81.36 | $231,876 | Direct |
| Jul 2, 2026 | ANIP ANI PHARMACEUTICALS INC | Exercise(M) | 3,313 | $49.51 | $164,027 | Direct |
| Jul 2, 2026 | ANIP ANI PHARMACEUTICALS INC | Sale(S) | 3,313 | $86.00 | $284,918 | Direct |
| Jun 29, 2026 | ANIP ANI PHARMACEUTICALS INC | Sale(S) | 2,850 | $84.12 | $239,742 | Direct |
| Jun 5, 2026 | ANIP ANI PHARMACEUTICALS INC | Exercise(M) | 3,312 | $49.51 | $163,977 | Direct |
| Jun 5, 2026 | ANIP ANI PHARMACEUTICALS INC | Sale(S) | 3,312 | $80.00 | $264,960 | Direct |
| Mar 7, 2026 | ANIP ANI PHARMACEUTICALS INC | Tax Payment(F) | 5,150 | $74.04 | $381,306 | Direct |
| Mar 5, 2026 | ANIP ANI PHARMACEUTICALS INC | Sale(S) | 3,312 | $75.42 | $249,791 | Direct |
| Mar 5, 2026 | ANIP ANI PHARMACEUTICALS INC | Sale(S) | 4,000 | $75.56 | $302,240 | Direct |
| Mar 5, 2026 | ANIP ANI PHARMACEUTICALS INC | Exercise(M) | 3,312 | $49.51 | $163,977 | Direct |
| Feb 28, 2026 | ANIP ANI PHARMACEUTICALS INC | Tax Payment(F) | 2,773 | $73.90 | $204,925 | Direct |
| Feb 26, 2026 | ANIP ANI PHARMACEUTICALS INC | Award(A) | 22,233 | $77.15 | $1,715,276 | Direct |
| Feb 14, 2026 | ANIP ANI PHARMACEUTICALS INC | Tax Payment(F) | 2,448 | $77.36 | $189,377 | Direct |
| Feb 12, 2026 | ANIP ANI PHARMACEUTICALS INC | Tax Payment(F) | 2,829 | $76.70 | $216,984 | Direct |
| Feb 11, 2026 | ANIP ANI PHARMACEUTICALS INC | Tax Payment(F) | 5,503 | $76.25 | $419,604 | Direct |
| Aug 12, 2025 | ANIP ANI PHARMACEUTICALS INC | Exercise(M) | 50,000 | $46.49 | $2,324,500 | Direct |
| Aug 12, 2025 | ANIP ANI PHARMACEUTICALS INC | Sale(S) | 50,000 | $86.07 | $4,303,500 | Direct |
| Mar 23, 2025 | ANIP ANI PHARMACEUTICALS INC | Tax Payment(F) | 6,210 | $64.26 | $399,055 | Direct |
| Mar 7, 2025 | ANIP ANI PHARMACEUTICALS INC | Tax Payment(F) | 5,150 | $60.62 | $312,193 | Direct |
| Feb 28, 2025 | ANIP ANI PHARMACEUTICALS INC | Tax Payment(F) | 1,861 | $61.89 | $115,177 | Direct |
| Feb 14, 2025 | ANIP ANI PHARMACEUTICALS INC | Tax Payment(F) | 1,730 | $58.92 | $101,932 | Direct |
| Feb 12, 2025 | ANIP ANI PHARMACEUTICALS INC | Award(A) | 16,538 | - | - | Direct |
1-25 of 27 transactions
About CAREY STEPHEN P.
CAREY STEPHEN P. (SEC CIK 0001674236) files insider reports with the SEC as SVP & CFO of ANI PHARMACEUTICALS INC (ANIP).
Signal8 holds 18 ownership filings by CAREY STEPHEN P., all Form 4s, filed between Dec 18, 2024 and Oct 30, 2026. Those filings report 27 transactions, from Dec 17, 2024 to Oct 29, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on CAREY STEPHEN P.'s filings is in PRINCETON, NJ.
Recent filings by CAREY STEPHEN P.
- Oct 29, 2026: Open-market sale of ANIP shares (Form 4, code S).
- Sep 29, 2026: Open-market sale of ANIP shares (Form 4, code S).
- Aug 31, 2026: Open-market sale of ANIP shares (Form 4, code S).
- Jul 29, 2026: Open-market sale of ANIP shares (Form 4, code S).
- Jul 2, 2026: Option exercise of ANIP shares (Form 4, code M).
Other insiders filing for ANI PHARMACEUTICALS INC (ANIP)
- Lalwani Nikhil, PRESIDENT & CEO
- Cook Meredith, SR. VP, GENERAL COUNSEL & SEC.
- Thoma Jeanne, Director
- Gosebruch Henry O, Director
- Gutwerg Ori, SVP, GENERICS
- TANNENBAUM RENEE P, Director